Related Experiment Video
Updated: Aug 14, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to
Peter Alter1, Heinz Rupp, Bernhard Maisch
1Philipps University of Marburg, Department of Internal Medicine-Cardiology, Germany. palter@med.uni-marburg.de
Insights
Nuclear factor-kappaB (NFkappaB) activation is elevated in myocarditis, correlating with preserved left ventricular function. This suggests NFkappaB plays a role in early inflammatory stages and may protect against cardiac dilation.
Area of Science:
- Cardiology
- Immunology
- Molecular Biology
Background:
- Myocarditis, an inflammation of the heart muscle, can be triggered by infections or autoimmune conditions.
- The role of persistent viral genomes and ongoing adverse processes in myocarditis pathogenesis remains unclear.
- Nuclear factor-kappaB (NFkappaB) is a key transcription factor implicated in inflammatory and remodeling processes.
Purpose of the Study:
- To investigate the activation status of NFkappaB in patients with myocarditis and its association with cardiac function and viral persistence.
- To determine if NFkappaB activation is linked to adverse cardiac remodeling in myocarditis.
Main Methods:
- Echocardiography and cardiac catheterization were used to assess hemodynamics in 93 patients with suspected myocarditis/cardiomyopathy.
- Endomyocardial biopsies were analyzed using immunohistochemistry and PCR for viral genomes and activated NFkappaB.
- Statistical analyses correlated NFkappaB levels with clinical parameters and viral presence.
Main Results:
- NFkappaB activation was significantly higher in myocarditis patients compared to controls, but not in dilated cardiomyopathy.
- Increased NFkappaB correlated with preserved left ventricular function and inversely with left ventricular end-diastolic volume.
- Adenovirus persistence was associated with increased NFkappaB activation, while cytomegalovirus and parvovirus B19 showed no significant association.
Conclusions:
- Elevated NFkappaB activation is linked to inflammatory processes in myocarditis.
- NFkappaB activation may occur in early inflammatory stages and potentially protect cardiomyocytes from apoptosis and cardiac dilation.
- The prognostic and therapeutic relevance of NFkappaB in myocarditis warrants further investigation.
Objectives And Background:
Myocarditis is caused by various agents and autoimmune processes. It is unknown whether viral genome persistence represents inactive remnants of previous infections or whether it is attributed to ongoing adverse processes. The latter also applies to the course of autoimmune myocarditis. One principal candidate for an adverse remodeling is nuclear factor-kappaB (NFkappaB).
Methods:
A total of 93 patients with suspected myocarditis/cardiomyopathy was examined. Hemodynamics were assessed by echocardiography as well as right and left heart catheterization. Endomyocardial biopsies were taken from the left ventricle. Biopsies were examined by immunohistochemistry and PCR for viral genomes. Selective immunostaining of activated NFkappaB was performed.
Results:
NFkappaB was increased in patients with myocarditis when compared with controls (11.1+/-7.1% vs. 5.0+/-5.3%, P<0.005) whereas dilated cardiomyopathy showed no significant increase. Patients with myocarditis and preserved left ventricular function exhibited increased activated NFkappaB when compared with reduced function (r2=0.72, P<0.001). In parallel, inverse correlation of NFkappaB and left ventricular enddiasstolic volume was found (r2=0.43, P<0.02). Increased activated NFkappaB was found in adenovirus persistence when compared with controls (P=0.001). Only a trend of increased NFkappaB activation was seen in cytomegalovirus persistence. Parvovirus B19 persistence did not affect NFkappaB activation.
Conclusions:
Increased activation of NFkappaB is related to inflammatory processes in myocarditis. Since activated NFkappaB correlates with left ventricular function, it could be assumed that NFkappaB activation occurs at early stages of inflammation. Potentially, NFkappaB could inhibit loss of cardiomyocytes by apoptosis and protect from cardiac dilation. Since NFkappaB is a crucial key transcription factor of inflammation, its prognostic and future therapeutic relevance should be addressed.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...